Indacaterol Onbrez For Chronic Obstructive Pulmonary Disease. It works by opening up the air passages in your lungs so that air can flow into your lungs more freely. Copd is a lung disease that affects breathing.
Phase ii studies were initiated in japan to evaluate the safety and efficacy of the drug in asthma patients in november 2006 and uses around 41 patients. How does indacaterol work for people with copd? Phase iii trials to evaluate safety and efficacy of twice daily doses were initiated in october 2006 and completed by august 2008.
The results of the trial were released in september 2010.
Around 210 million people worldwide suffer from copd and in europe the number of patients suffering from copd is around 82 million. The results of the trial were released in september 2010. Copd is a lung disease that affects breathing. How is onbrez breezhaler used in copd patients?
Post a Comment for "Indacaterol Onbrez For Chronic Obstructive Pulmonary Disease"